| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $200K | -88.9% |
| R&D Expense | $203.7M | +6.3% |
| SG&A Expense | $127.9M | +335.3% |
| Operating Income | -$331.4M | -51.2% |
| Pre-tax Income | $1.69B | +804.0% |
| Income Tax | $2K | -33.3% |
| Net Income | $1.69B | +799.2% |
| EPS (Basic) | $114.01 | +656.7% |
| EPS (Diluted) | $112.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $152.6M | -45.1% |
| Current Assets | $160.4M | -45.7% |
| Total Assets | $180.8M | -41.3% |
| Current Liabilities | $40.7M | -27.7% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $47.2M | -82.2% |
| Stockholders' Equity | $133.6M | +207.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$194.4M | -0.6% |
| Capital Expenditures | $2.6M | -43.5% |
| Investing Cash Flow | -$2.6M | +43.5% |
| Financing Cash Flow | $71.7M | -64.5% |
| Free Cash Flow | -$197.0M | +0.5% |
| +649.9% |